Mechanistic Target of Rapamycin Complex 2 Protects the Heart From Ischemic Damage

Abstract

These results suggest that selectively increasing mTORC2 while concurrently inhibiting mTORC1 signaling is a novel therapeutic approach for the treatment of ischemic heart disease.